Does prior short-course nevirapine reduce the effectiveness of subsequent combination treatment with efavirenz?

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):348-50. doi: 10.1097/00126334-200311010-00017.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Alkynes
  • Antiretroviral Therapy, Highly Active / methods*
  • Antiretroviral Therapy, Highly Active / standards
  • Benzoxazines
  • CD4 Lymphocyte Count
  • Cyclopropanes
  • Drug Interactions
  • Drug Therapy, Combination
  • Female
  • HIV Infections / drug therapy*
  • HIV-1*
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Nevirapine / administration & dosage
  • Nevirapine / pharmacology*
  • Oxazines / administration & dosage
  • Oxazines / pharmacology*
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / pharmacology*

Substances

  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • efavirenz